-
1
-
-
80155177841
-
Elevated free fatty acid is associated with cardioembolic stroke subtype
-
Seo W-K, Kim J, Kim YH, et al. Elevated free fatty acid is associated with cardioembolic stroke subtype. Can J Neurol Sci. 2011; 38(6):874-9.
-
(2011)
Can J Neurol Sci
, vol.38
, Issue.6
, pp. 874-879
-
-
Seo, W.-K.1
Kim, J.2
Kim, Y.H.3
-
2
-
-
84881317939
-
Effects of vitamin e on stroke subtypes: Meta-analysis of randomised controlled trials
-
Schurks M, Glynn RJ, Rist PM, et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702.
-
(2010)
BMJ
, vol.341
-
-
Schurks, M.1
Glynn, R.J.2
Rist, P.M.3
-
3
-
-
80053518247
-
Oxidative stress is activated by free fatty acids in cultured human hepatocytes
-
ePub ahead of print May 11, 2011
-
Soardo G, Donnini D, Domenis L, et al. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord. 2011;ePub ahead of print May 11, 2011.
-
(2011)
Metab Syndr Relat Disord
-
-
Soardo, G.1
Donnini, D.2
Domenis, L.3
-
4
-
-
77955925923
-
Control of fibrinogen biosynthesis: Role of the FFA/albumin ratio
-
Pilgeram L. Control of fibrinogen biosynthesis: role of the FFA/albumin ratio. Cardiovasc Eng. 2010;10:78-83.
-
(2010)
Cardiovasc Eng
, vol.10
, pp. 78-83
-
-
Pilgeram, L.1
-
5
-
-
0035143478
-
Fats lipids and blood coagulation
-
MutanenM, Freese R. Fats, lipids and blood coagulation. Curr Opin Lipidol. 2001;12:25-9.
-
(2001)
Curr Opin Lipidol
, vol.12
, pp. 25-29
-
-
Mutanen, M.1
Freese, R.2
-
6
-
-
0022512576
-
Association between dietary fat intake and plasma factor VII coagulant activity. A predictor of cardiovascular mortality
-
Miller GJ, Martin JC, Webster J, et al. Association between dietary fat intake and plasma factor VII coagulant activity-a predictor of cardiovascular mortality. Atherosclerosis. 1986;60:269-77. (Pubitemid 16035624)
-
(1986)
Atherosclerosis
, vol.60
, Issue.3
, pp. 269-277
-
-
Miller, G.J.1
Martin, J.C.2
Webster, J.3
-
7
-
-
33749543001
-
Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients
-
DOI 10.1016/j.metabol.2005.11.010, PII S0026049505004439
-
Rigla M, Wagner AM, Borrell M, et al. Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients. Metabolism. 2006;55: 1437-42. (Pubitemid 44537340)
-
(2006)
Metabolism: Clinical and Experimental
, vol.55
, Issue.11
, pp. 1437-1442
-
-
Rigla, M.1
Wagner, A.M.2
Borrell, M.3
Mateo, J.4
Foncuberta, J.5
De Leiva, A.6
Ordonez-Llanos, J.7
Perez, A.8
-
8
-
-
0033972031
-
Effect of ω-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia
-
Nordoy A, Bonaa KH, Sandset PM, et al. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia. Arterioscler Thromb Vasc Biol. 2000;20:259-65. (Pubitemid 30048373)
-
(2000)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.20
, Issue.1
, pp. 259-265
-
-
Nordoy, A.1
Bonaa, K.H.2
Sandset, P.M.3
Hansen, J.-B.4
Nilsen, H.5
-
9
-
-
26444612124
-
Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: The role of homocysteine
-
DOI 10.1161/01.STR.0000183620.06179.7b
-
Poli D, Antonucci E, Cecchi E, et al. Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke. 2005;36:2159-63. (Pubitemid 41429238)
-
(2005)
Stroke
, vol.36
, Issue.10
, pp. 2159-2163
-
-
Poli, D.1
Antonucci, E.2
Cecchi, E.3
Marcucci, R.4
Liotta, A.A.5
Cellai, A.P.6
Lenti, M.7
Gensini, G.F.8
Abbate, R.9
Prisco, D.10
-
10
-
-
34547743420
-
Homocysteine-lowering therapy: A role in stroke prevention?
-
DOI 10.1016/S1474-4422(07)70219-3, PII S1474442207702193
-
Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;7:830-8. (Pubitemid 47241275)
-
(2007)
Lancet Neurology
, vol.6
, Issue.9
, pp. 830-838
-
-
Spence, J.D.1
-
11
-
-
33645757846
-
Trans fatty acids and cardiovascular disease
-
Mozaffarian D, Katan MB, Ascherio A, et al. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601-13.
-
(2006)
N Engl J Med
, vol.354
, pp. 1601-1613
-
-
Mozaffarian, D.1
Katan, M.B.2
Ascherio, A.3
-
12
-
-
78549268838
-
Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease
-
Spence JD, Jenkins DJ, Davignon J. Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Can J Cardiol. 2010;26:e336-e9.
-
(2010)
Can J Cardiol
, vol.26
-
-
Spence, J.D.1
Jenkins, D.J.2
Davignon, J.3
-
13
-
-
77956343501
-
Secondary stroke prevention
-
Spence JD. Secondary stroke prevention. Nat Rev Neurol. 2010;6: 477-86.
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 477-486
-
-
Spence, J.D.1
|